跳至主要内容
临床试验/JPRN-UMIN000010200
JPRN-UMIN000010200招募中2 期

Phase II study of chemotherapy with Capecitabine/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer - Phase II study of chemotherapy with Capecitabine/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer

Yamafuchi University Medical Bioregulation Department of Organ Regulatory Surgery0 个研究点目标入组 30 人开始时间: 2013年3月11日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)active brain metastases (2) Complication of cerebrovascular disease or symptoms within 1 year (3) Patient receiving surgical procedure or such as skin-open biopsy, trauma surgery, or other more intensive surgeries within 4 weeks or aspiration biopsy within a week (4) History of gastrointestinal perforation within 1 year. (5) Uncontrollable peptic ulcer, Hypertension, diarrhea, infections (6) A bleeding tendency, coagulation disorder or abnormal coagulation factor (7) bleeding diathesis or receiving anticoagulant drug(except Aspirin under 325mg/day) (8) Serious heart disease (9) History of active double cancer within 5 years (10)History of the serious hypersensitivity for capecitabine or bevacizumab (11)Other conditions not suitable for this study

研究者

发起方
Yamafuchi University Medical Bioregulation Department of Organ Regulatory Surgery

相似试验

Phase II study of chemotherapy with... | 临床试验